A detailed history of Gordian Capital Singapore Pte LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Gordian Capital Singapore Pte LTD holds 815 shares of LLY stock, worth $625,724. This represents 0.47% of its overall portfolio holdings.

Number of Shares
815
Previous 409 99.27%
Holding current value
$625,724
Previous $370,000 95.14%
% of portfolio
0.47%
Previous 0.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $313,488 - $389,768
406 Added 99.27%
815 $722,000
Q2 2024

Aug 30, 2024

SELL
$724.87 - $909.04 $392,154 - $491,790
-541 Reduced 56.95%
409 $370,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $562,590 - $752,666
950 New
950 $739,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gordian Capital Singapore Pte LTD Portfolio

Follow Gordian Capital Singapore Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gordian Capital Singapore Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gordian Capital Singapore Pte LTD with notifications on news.